RxSight (RXST) Accumulated Depreciation & Amortization (2020 - 2025)

RxSight has reported Accumulated Depreciation & Amortization for 6 years, with the latest figure at $3.3 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 8.33% year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (down 8.33% YoY), and the FY2025 full-year result was $3.3 million, down 8.33% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $3.3 million, down from $3.6 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $4.1 million in Q4 2023, with the low at $3.3 million in Q4 2025.
• Historically, Accumulated Depreciation & Amortization has averaged $3.8 million across 5 years, with a median of $3.9 million in 2022.
• Annual changes were most pronounced in 2023 — Accumulated Depreciation & Amortization gained 5.13% — and 2024, when it decreased 12.2%.
• RxSight's Accumulated Depreciation & Amortization stood at $4.0 million in 2021, then retreated by 2.5% to $3.9 million in 2022, then climbed by 5.13% to $4.1 million in 2023, then dropped by 12.2% to $3.6 million in 2024, then fell by 8.33% to $3.3 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $3.3 million (Q4 2025), $3.6 million (Q4 2024), and $4.1 million (Q4 2023), per Business Quant data.